P. Carmeliet, N. Mackman, L. Moons, T. Luther, and P. Gressens, Role of tissue factor in embryonic blood vessel development, Nature, vol.383, issue.6595, pp.73-75, 1996.
DOI : 10.1038/383073a0

M. Belting, J. Ahamed, and W. Ruf, Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.8, pp.1545-1550, 2005.
DOI : 10.1161/01.ATV.0000171155.05809.bf

N. Mackman, The Role of Tissue Factor and Factor VIIa in Hemostasis, Anesthesia & Analgesia, vol.108, issue.5, pp.1447-1452, 2009.
DOI : 10.1213/ane.0b013e31819bceb1

Y. Van-den-berg, S. Osanto, P. Reitsma, and H. Versteeg, The relationship between tissue factor and cancer progression: insights from bench and bedside, Blood, vol.119, issue.4, pp.924-932, 2012.
DOI : 10.1182/blood-2011-06-317685

U. Bavendiek, P. Libby, M. Kilbride, R. Reynolds, N. Mackman et al., Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor kappa B, and Egr-1, Journal of Biological Chemistry, vol.277, issue.28, pp.25032-25039, 2002.
DOI : 10.1074/jbc.M204003200

X. Zhang, H. Yu, J. Lou, J. Zheng, H. Zhu et al., MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells, Journal of Biological Chemistry, vol.286, issue.2, pp.1429-1435, 2011.
DOI : 10.1074/jbc.M110.146530

J. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa et al., Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis, Blood, vol.105, issue.4, pp.1734-1775, 2005.
DOI : 10.1182/blood-2004-05-2042

. Rongy, . Belozerovve, . Tucker-burdenc, . Cheng, . Durdendl et al., Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity, Cancer Research, vol.69, issue.6, pp.2540-2549, 2009.
DOI : 10.1158/0008-5472.CAN-08-1547

J. Zhou, S. Ljungdahl, M. Shoshan, J. Swedenborg, and S. Linder, Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway, Molecular Carcinogenesis, vol.9, issue.4, pp.234-243, 1998.
DOI : 10.1002/(SICI)1098-2744(199804)21:4<234::AID-MC2>3.0.CO;2-K

M. Guha, O. Connell, M. Pawlinski, R. Hollis, A. Mcgovern et al., Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood, vol.98, issue.5, pp.1429-1439, 2001.
DOI : 10.1182/blood.V98.5.1429

J. Steffel, T. Lüscher, and F. Tanner, Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications, Circulation, vol.113, issue.5, pp.722-731, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.567297

Y. Van-den-berg and H. Versteeg, Alternatively spliced tissue factor. A crippled protein in coagulation ora key player in non haemostatic processes, Hamostaseologie, vol.30, pp.144-149, 2010.

V. Bogdanov, V. Balasubramanian, J. Hathcock, O. Vele, M. Lieb et al., Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein, Nature Medicine, vol.9, issue.4, pp.458-462, 2003.
DOI : 10.1038/nm841

R. Srinivasan and V. Bogdanov, Alternatively spliced Tissue Factor: discovery, insights, clinical implications, Frontiers in Bioscience, vol.16, issue.1, pp.3061-3071, 2011.
DOI : 10.2741/3899

A. Eisenreich, R. Malz, W. Pepke, Y. Ayral, W. Poller et al., Role of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Regulating Alternative Splicing of Tissue Factor mRNA in Human Endothelial Cells, Circulation Journal, vol.73, issue.9, pp.1746-1752, 2009.
DOI : 10.1253/circj.CJ-99-0225

Y. Van-den-berg, L. Van-den-hengel, H. Myers, O. Ayachi, E. Jordanova et al., Alternatively spliced tissue factor induces angiogenesis through integrin ligation, Proceedings of the National Academy of Sciences, vol.106, issue.46, pp.19497-19502, 2009.
DOI : 10.1073/pnas.0905325106

J. Hobbs, A. Zakarija, D. Cundiff, J. Doll, E. Hymen et al., Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model, Thrombosis Research, vol.120, pp.13-21, 2007.
DOI : 10.1016/S0049-3848(07)70126-3

P. Goldin-lang, Q. Tran, I. Fichtner, A. Eisenreich, S. Antoniak et al., Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis, Oncology Reports, vol.20, pp.123-128, 2008.
DOI : 10.3892/or.20.1.123

T. Ueno, M. Toi, M. Koike, S. Nakamura, and T. Tominaga, Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration, Br J Cancer, vol.83, pp.164-170, 2000.

J. Yan, K. Wang, L. Dong, H. Liu, W. Chen et al., PML/RAR?? fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association, Proceedings of the National Academy of Sciences, vol.107, issue.8, pp.3716-3721, 2010.
DOI : 10.1073/pnas.0915006107

B. Szotowski, P. Goldin-lang, S. Antoniak, V. Bogdanov, D. Pathirana et al., Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy, Journal of the American College of Cardiology, vol.45, issue.7, pp.1081-1090, 2005.
DOI : 10.1016/j.jacc.2004.12.061

Y. Gan, C. Shi, L. Inge, M. Hibner, J. Balducci et al., Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells, Oncogene, vol.6, issue.35, pp.4947-4958, 2010.
DOI : 10.1038/onc.2010.240

W. Chappell, L. Steelman, J. Long, R. Kempf, S. Abrams et al., Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health, Oncotarget, vol.2, issue.3, pp.135-164, 2011.
DOI : 10.18632/oncotarget.240

G. Schabbauer, M. Tencati, B. Pedersen, R. Pawlinski, and N. Mackman, PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.10, pp.1963-1969, 2004.
DOI : 10.1161/01.ATV.0000143096.15099.ce

M. Guha, O. Connell, M. Pawlinski, R. Hollis, A. Mcgovern et al., Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood, vol.98, issue.5, pp.1429-1439, 2001.
DOI : 10.1182/blood.V98.5.1429

L. Ding, W. Ma, T. Littmann, R. Camp, and J. Shen, Nucleotide Receptor Mediates Tissue Factor Expression in Human Coronary Artery Endothelial Cells, Journal of Biological Chemistry, vol.286, issue.30, pp.27027-27038, 2011.
DOI : 10.1074/jbc.M111.235176

H. Hayashi, Y. Tsuchiya, K. Nakayama, T. Satoh, and E. Nishida, Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling, Genes to Cells, vol.276, issue.9, pp.941-947, 2008.
DOI : 10.1111/j.1365-2443.2008.01218.x

D. Fabbro, S. Cowan-jacob, H. Möbitz, and G. Martiny-baron, Targeting Cancer with Small-Molecular-Weight Kinase Inhibitors, Methods Mol Biol, vol.795, pp.1-34, 2012.
DOI : 10.1007/978-1-61779-337-0_1

J. Lig?za, J. Lig?za, and A. Klein, Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells, Acta Biochim Pol, vol.58, pp.391-396, 2011.

T. Popova, V. Espina, C. Bailey, L. Liotta, E. Petricoin et al., Anthrax infection inhibits the AKT signaling involved in the E-cadherin-mediated adhesion of lung epithelial cells, FEMS Immunology & Medical Microbiology, vol.56, issue.2, pp.129-142, 2009.
DOI : 10.1111/j.1574-695X.2009.00558.x

S. Chandradas, G. Deikus, J. Tardos, and V. Bogdanov, Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells, Journal of Leukocyte Biology, vol.87, issue.1, pp.147-152, 2010.
DOI : 10.1189/jlb.0409252

J. Mccubrey, L. Steelman, S. Abrams, J. Lee, F. Chang et al., Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Advan Enzyme Regul, pp.249-279, 2006.

G. Lurje and H. Lenz, EGFR Signaling and Drug Discovery, Oncology, vol.77, issue.6, pp.400-410, 2009.
DOI : 10.1159/000279388

. Hu, Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells, Journal of Hematology & Oncology, vol.5, issue.1, p.16, 2012.
DOI : 10.1159/000279388

URL : https://hal.archives-ouvertes.fr/inserm-00716982